N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma

MLA

Yuanlei Chen, et al. “N6-Methyladenosine-Modified TRAF1 Promotes Sunitinib Resistance by Regulating Apoptosis and Angiogenesis in a METTL14-Dependent Manner in Renal Cell Carcinoma.” Molecular Cancer, vol. 21, no. 1, May 2022, pp. 1–17. EBSCOhost, https://doi.org/10.1186/s12943-022-01549-1.

APA

Yuanlei Chen, Zeyi Lu, Chao Qi, Chenhao Yu, Yang Li, Wang Huan, Ruyue Wang, Wenqin Luo, Danyang Shen, Lifeng Ding, Liangliang Ren, Haiyun Xie, Dingwei Xue, Mingchao Wang, Kangxin Ni, Liqun Xia, Jun Qian, & Gonghui Li. (2022). N6-methyladenosine-modified TRAF1 promotes sunitinib resistance by regulating apoptosis and angiogenesis in a METTL14-dependent manner in renal cell carcinoma. Molecular Cancer, 21(1), 1–17. https://doi.org/10.1186/s12943-022-01549-1

Chicago

Yuanlei Chen, Zeyi Lu, Chao Qi, Chenhao Yu, Yang Li, Wang Huan, Ruyue Wang, et al. 2022. “N6-Methyladenosine-Modified TRAF1 Promotes Sunitinib Resistance by Regulating Apoptosis and Angiogenesis in a METTL14-Dependent Manner in Renal Cell Carcinoma.” Molecular Cancer 21 (1): 1–17. doi:10.1186/s12943-022-01549-1.